Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | CNR1 | P21554 | 2/20 | 0.35 |
| ▸ | CNR2 | P34972 | 2/20 | 0.35 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.34 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.33 |
| ▸ | DRD2 | P14416 | 1/20 | 0.33 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.33 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.33 |
| ▸ | PDE7A | Q13946 | 1/20 | 0.33 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.32 |
| ▸ | SLC5A2 | P31639 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7635408 | 0.88 | KDM4E (0.38) | ALDH1A1CYP3A4KDM4ELMNAPOLB | |
| SCHEMBL8439467 | 0.77 | ALDH1A1 (0.36) | ALDH1A1CYP3A4KDM4ELMNAPOLB | |
| SCHEMBL4978016 | 0.76 | ALDH1A1 (0.41) | ALDH1A1CYP3A4CNR1CNR2P2RX3 | |
| SCHEMBL7635398 | 0.69 | ALDH1A1 (0.39) | ALDH1A1CYP3A4POLBCNR1CNR2 | |
| SCHEMBL7570871 | 0.67 | ALDH1A1 (0.36) | ALDH1A1CYP3A4P2RX3TAAR1DRD2 | |
| SCHEMBL7634751 | 0.62 | ALDH1A1 (0.38) | ALDH1A1CYP3A4LMNACNR2PDE4D | |
| SCHEMBL8335941 | 0.62 | ALDH1A1 (0.35) | ALDH1A1CYP3A4NPSR1CNR1P2RX3 | |
| SCHEMBL5466563 | 0.61 | ALDH1A1 (0.44) | ALDH1A1CYP3A4CNR1CNR2TAAR1 | |
| SCHEMBL77492 | 0.61 | CA2 (0.59) | ALDH1A1KDM4ENPSR1TAAR1 | |
| SCHEMBL2135113 | 0.61 | TAAR1 (0.68) | LMNATAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080064756-A1 | Use of Alcohol-Oxyalkylates in the Form of Adjuvants for Benzamidoxime Fungicidal Derivatives, Appropriate Agents and Kits | BASF AKTIENGESELLSCHAFT (DE) | 2008-03-13 | — | — | US | disclosed |
| US-7101900-B2 | Benzyl amidoxime derivatives, intermediate products and method for their production and use as fungicides | BASF AKTIENGESELLSCHAFT (DE) | 2006-09-05 | — | — | US | disclosed |
| US-20050187265-A1 | Novel benzyl amidoxime derivatives, intermediate products and method for their production and use as fungicides | RHEINHEIMER JOACHIM (DE) | 2005-08-25 | — | — | US | disclosed |
| EP-1003725-B1 | FLUOROPYRAZOLE-BIPHENYLAMIDE FUNGICIDES | BASF AG (DE) | 2004-12-29 | — | — | EP | disclosed |
| EP-1257172-B1 | FUNGICIDAL AGENTS CONTAINING PYRROLIDONES AS THEIR ACTIVE AGENTS AND USE THEREOF FOR TREATING PLANTS | BASF AG (DE) | 2004-10-13 | — | — | EP | disclosed |
| US-6680402-B2 | SUCH AS N-PHENYLACETYL-2-DIFLUOROMETHOXY-6-FLUOROBENZAMIDE-O-CYCLOPROPYLMETHYL OXIME | BASF AKTIENGESELLSCHAFT (DE) | 2004-01-20 | — | — | US | disclosed |
| US-6680283-B1 | TREATMENT OF PLANTS, AND ALSO FOR THE THERAPEUTIC TREATMENT OF HUMAN DISORDERS CAUSED BY HARMFUL FUNGI, AND FOR THE VETERINARY TREATMENT OF MAMMALS | BASF AKTIENGESELLSCHAFT (DE) | 2004-01-20 | — | — | US | disclosed |
| EP-1218339-B1 | BENZYL AMIDOXIME DERIVATIVES, INTERMEDIATE PRODUCTS AND METHOD FOR THEIR PRODUCTION AND USE AS FUNGICIDES | BASF AG (DE) | 2003-10-01 | — | — | EP | disclosed |
| US-6586369-B1 | Agriculture | BASF AKTIENGESELLSCHAFT (DE) | 2003-07-01 | — | — | US | disclosed |
| US-20030120085-A1 | Novel benzamidoxime derivatives, intermediates and processes for their preparation, and their use as fungicides | EICKEN KARL (DE) | 2003-06-26 | — | — | US | disclosed |
| EP-0672654-B1 | Fungicidal carbamoyloxime carbonic acid amides | BASF AG (DE) | 1997-09-10 | — | — | EP | disclosed |
| EP-0763014-A1 | CARBAMOYL CARBOXYLIC ACID HYDRAZIDES AND THEIR USE AGAINST FUNGI | BASF AKTIENGESELLSCHAFT (DE) | 1997-03-19 | — | — | EP | disclosed |
| WO-1997008148-A1 | HETEROCYCLICALLY SUBSTITUTED BIPHENYLAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS FUNGICIDES | BASF AKTIENGESELLSCHAFT (DE) | 1997-03-06 | — | — | WO | disclosed |
| WO-1997008147-A1 | N-HETEROCYCLIC COMPOUNDS, INTERMEDIATE PRODUCTS USED TO PREPARE THEM, AGENTS CONTAINING THEM AND THEIR USE IN ANTIFUNGAL APPLICATIONS | BASF AKTIENGESELLSCHAFT (DE) | 1997-03-06 | — | — | WO | disclosed |
| WO-1997008138-A1 | CARBAMOYL CARBOXYLIC ACID AMIDES | BASF AKTIENGESELLSCHAFT (DE) | 1997-03-06 | — | — | WO | disclosed |
| WO-1997006133-A1 | HYDROXIMIC ACID DERIVATIVES, A PROCESS FOR PREPARING THE SAME AND THEIR USE AS PESTICIDES AND FUNGICIDES | BASF AKTIENGESELLSCHAFT (DE) | 1997-02-20 | — | — | WO | disclosed |
| WO-1996024249-A1 | FUNGICIDE | BASF AKTIENGESELLSCHAFT (DE) | 1996-08-15 | — | — | WO | disclosed |
| WO-1995033710-A1 | CARBAMOYL CARBOXYLIC ACID HYDRAZIDES AND THEIR USE AGAINST FUNGI | BASF AKTIENGESELLSCHAFT (DE) | 1995-12-14 | — | — | WO | disclosed |
| EP-0672654-A1 | Fungicidal carbamoyloxime carbonic acid amides | BASF AKTIENGESELLSCHAFT (DE) | 1995-09-20 | — | — | EP | disclosed |
| WO-1995023786-A1 | CARBAMOYL CARBOXYLIC ACID AMIDES, PROCESS FOR PRODUCING THEM AND THEIR USE AS FUNGICIDES | BASF AKTIENGESELLSCHAFT (DE) | 1995-09-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080064756-A1 | Use of Alcohol-Oxyalkylates in the Form of Adjuvants for Benzamidoxime Fungicidal Derivatives, Appropriate Agents and Kits | ADH5, AOX1, CYP2E1 | ALDH1A1 54/4885CYP3A4 146/4885KDM4E 757/4885 |
| US-20050187265-A1 | Novel benzyl amidoxime derivatives, intermediate products and method for their production and use as fungicides | CBR3, CBR1, CYP1B1 | ALDH1A1 1086/4885CYP3A4 32/4885KDM4E 3789/4885 |
| US-20030120085-A1 | Novel benzamidoxime derivatives, intermediates and processes for their preparation, and their use as fungicides | CBR1, CBR3, CYP1B1 | ALDH1A1 316/4885CYP3A4 12/4885KDM4E 587/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.